Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Disease Area

Disease Area Professional development

A Second Tour of Duty… Lessons Learned with Annalisa Jenkins

| James Strachan

Annalisa explains how the military gave her an excellent platform to launch a high-level career in pharma.

Disease Area Drug discovery

Beating the Resistance

| William Aryitey

Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?

Disease Area Pain & critical care

Resisting Arrest

| Roisin McGuigan

Could resonance Raman spectroscopy be the key to your heart?

Disease Area Public health

Fostering Better care

| Michael Schubert

Children entering foster care are receiving extensive screening – but is it cost-effective?

Disease Area Drug discovery

Pain and Vision Gain

| Roisin McGuigan

An analgesic is helping researchers explore new drug targets for sight-threatening diseases

Disease Area Diagnostics & prognostics

Dark Fields and Diagnostic Disks

| Michael Schubert

New devices for detecting tuberculosis may speed up diagnosis and improve treatment

Disease Area Microbiology

From MS to AMR

| Roisin McGuigan

A drug used to treat MS could be repurposed to treat infections in cystic fibrosis patients

Disease Area Drug delivery

The Next (Air)Wave of Inhalables

| David Lewis

For inhaler technology to evolve, questions about efficacy must be answered

Disease Area Outcomes research

A Stitch in Time

| Roisin McGuigan

Recent research finds that it may be best to have heart surgery after lunch

Disease Area Public health

Sepsis and Serendipity

| Roisin McGuigan

Could an accidental discovery lead to a cure for sepsis?

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register